Gladius Capital Management LP Takes $42,000 Position in Avantor, Inc. (NYSE:AVTR)

Gladius Capital Management LP purchased a new position in Avantor, Inc. (NYSE:AVTR) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,855 shares of the company’s stock, valued at approximately $42,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AVTR. Commonwealth Equity Services LLC acquired a new stake in shares of Avantor during the third quarter worth $207,000. Robeco Institutional Asset Management B.V. lifted its holdings in Avantor by 52.5% in the third quarter. Robeco Institutional Asset Management B.V. now owns 19,015 shares of the company’s stock worth $401,000 after acquiring an additional 6,543 shares during the last quarter. Xponance Inc. boosted its stake in Avantor by 6.3% in the third quarter. Xponance Inc. now owns 25,396 shares of the company’s stock valued at $535,000 after acquiring an additional 1,502 shares during the period. Raymond James & Associates boosted its stake in Avantor by 22.8% in the third quarter. Raymond James & Associates now owns 630,745 shares of the company’s stock valued at $13,296,000 after acquiring an additional 117,257 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Avantor by 2.5% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 355,472 shares of the company’s stock valued at $7,493,000 after purchasing an additional 8,659 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on AVTR shares. Barclays boosted their price objective on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. JPMorgan Chase & Co. upped their price target on shares of Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Raymond James lifted their price objective on shares of Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research report on Friday, January 26th. UBS Group upped their target price on shares of Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Finally, Citigroup lifted their price target on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $26.71.

Avantor Price Performance

AVTR traded up $0.50 during trading on Thursday, reaching $24.78. The stock had a trading volume of 2,904,562 shares, compared to its average volume of 5,706,803. The stock has a 50 day moving average of $25.10 and a two-hundred day moving average of $22.81. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $16.83 billion, a price-to-earnings ratio of 63.54, a price-to-earnings-growth ratio of 1.50 and a beta of 1.36. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $26.16.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.68 billion. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The company’s revenue was down 5.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.29 earnings per share. As a group, equities analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Insider Buying and Selling at Avantor

In related news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the sale, the executive vice president now directly owns 101,143 shares in the company, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.50% of the stock is owned by corporate insiders.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.